Bacteriophage-derived endolysins to target gram-negative bacteria
- 30 August 2020
- journal article
- review article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 589, 119833
- https://doi.org/10.1016/j.ijpharm.2020.119833
Abstract
No abstract availableKeywords
Funding Information
- Chinese University of Hong Kong
This publication has 93 references indexed in Scilit:
- A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic EnzymesJournal of Visualized Experiments, 2012
- Structural engineering of a phage lysin that targets Gram-negative pathogensProceedings of the National Academy of Sciences of the United States of America, 2012
- Characterization of Modular Bacteriophage Endolysins from Myoviridae Phages OBP, 201φ2-1 and PVP-SE1PLOS ONE, 2012
- Lag Phase Is a Distinct Growth Phase That Prepares Bacteria for Exponential Growth and Involves Transient Metal AccumulationJournal of Bacteriology, 2012
- Role of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage LysinsOnline Journal of Public Health Informatics, 2011
- Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteriaApplied Microbiology and Biotechnology, 2011
- Colistin in the 21st centuryCurrent Opinion in Infectious Diseases, 2009
- Bacteriophage lysins as effective antibacterialsCurrent Opinion in Microbiology, 2008
- Medical biofilmsBiotechnology & Bioengineering, 2008
- LambdaSa1 and LambdaSa2 Prophage Lysins of Streptococcus agalactiaeApplied and Environmental Microbiology, 2007